Stock listing

B3:U2TH34 United Therapeutics Corporation Ações

Brazilian listing (B3) of United Therapeutics Corporation · home listing NASDAQ:UTHR

Follow United Therapeutics Corporation into a list and get an email when it puts out news.

Share price · BMFBOVESPA:U2TH34

157.10 BRL +11.90 (+8.2%)

Close on Oct 27, 2026

Day range
157.10 – 157.10 BRLOct 27, 2026
Volume
200 sharesOct 27, 2026
United Therapeutics Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:UTHR · Home$601.32 USD+5.19 (+0.9%)595,233$596.14$606.16$596.14$596.13Close on Nov 3, 2026
B3:U2TH34157.10 BRL+11.90 (+8.2%)200157.10157.10157.10145.20Close on Oct 27, 2026
Frankfurt:UTH€525.00 EUR-0.80 (-0.2%)—€525.00€525.00€525.00€525.80Close on Oct 30, 2026
Munich:UTH€525.80 EUR+8.00 (+1.5%)—€525.80€525.80€525.80€517.80Close on Oct 27, 2026
Ticker
B3:U2TH34
Asset type
Stock
Exchange
B3
Currency
BRL

What changed lately

Calls

Upcoming

  • United Therapeutics (NASDAQ:UTHR) Q3 2026 Earnings Call

    Wed, Nov 04, 2026 · 9:00 AM ET

    Register

Replays

  • United Therapeutics (NASDAQ:UTHR) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 9:00 AM ET

    Watch Transcript

  • United Therapeutics (NASDAQ:UTHR) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 9:00 AM ET

    Watch Transcript

  • United Therapeutics (NASDAQ:UTHR) Q4 2025 Earnings Call

    Wed, Feb 25, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

United Therapeutics Announces FDA Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost SMI in Pulmonary Arterial Hypertension

Oct 28, 2026

United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization

Oct 22, 2026

United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026

Oct 21, 2026

United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility

Oct 20, 2026

United Therapeutics Announces FDA Clearance to Proceed with SUMMIT Clinical Trial for Treprostinil SMI in PH-COPD

Oct 19, 2026

United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting

Oct 13, 2026

United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

Sep 30, 2026

United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization

Sep 8, 2026

United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis

Sep 2, 2026

United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences

Sep 1, 2026

All United Therapeutics Corporation news

Decks

United Therapeutics Corporation on 6ix

News releases
46 in the last 12 months · 224 in all · newest Oct 28, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Aug 5, 2026
Decks
22 decks · latest Aug 5, 2026

Where United Therapeutics Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:UTHR · Home listingNASDAQUnited StatesUSD
gettex:UTHgettexGermanyEUR
LS Exchange:923818LS ExchangeGermanyEUR
Lang & Schwarz:923818Lang & SchwarzGermanyEUR
BMV:UTHRBMVMexicoMXN
Tradegate:UTHTradegateGermanyEUR
B3:U2TH34 · This pageB3BrazilBRL
Frankfurt:UTHFrankfurtGermanyEUR
Munich:UTHMunichGermanyEUR
BIVA:UTHRBIVAMexicoMXN
BOATS:UTHRBOATSUnited StatesUSD
BX Swiss:UTHBX SwissSwitzerlandCHF
Dusseldorf:UTHDusseldorfGermanyEUR
Stuttgart:UTHStuttgartGermanyEUR
Hamburg:UTHHamburgGermanyEUR
Hanover:UTHHanoverGermanyEUR

Log in to ask 6ix AI your own questions about United Therapeutics Corporation.